Epstein Secrets

-99, 69 S.Q. 968, 93 L.Ed. 1231 (1949) (recogniz- ing that the threat of prosecution may deny fishermen the right to earn a liveli- hood); Truax v. Raich, 289 U.S. 88, 88-89, 86 S.Ct. 7, 60 L.Ed. 131 (1915) (recognizing that the threat of prosecution may lead to an unconstitutional denial of the rig

Co. k Sher- man. 266 U.S. 497, 600, 46 .Ct. 41, 69 L.Ed 402 (1926); Terrace Thompson, I 263 U.S. 197, 214, 4eXCL 5, 68 L.Ed. 255 (1923); Truax Reich, 239 U.S. 33, 87, 36 S.Ct. 7, Ed. 131 (1915). We do not, by affirming, therefore, sug- gest agreement with a possible interpre- tation of the dist

ith their access to the drug. The Supreme Court rejected the patients' claims. The Court agreed with FDA that the new drug approval provisions of the Food, Drug, and Cosmetic Act spe- cifically applied to the situation presented. (171 In one respect, however, the fact that Dr. Burzynski and his patients wer

claimed to have made his fortune managing other rich people's money, was not just wealthy; he was poli

t it contemplates his criminal prosecution." Kordel, 397 U.S. at 11-12 (emphasis added). In Kordel, a corporate executive was convicted of violating the Food, Drug, and Cosmetic Act partly on the basis of earlier answers to interrogatories served on his company by the Food and Drug Administration (FDA) in a ci

claimed to have made his fortune managing other rich people's money, was not just wealthy; he was poli

it contemplates his criminal prosecution." Kordel, 397 U.S. at 11-12 (emphasis added). In Kordel, a corporate executive was convicted of violating the Food, Drug, and Cosmetic Act partly on the basis of earlier answers to interrogatories served on his company by the Food and Drug Administration (FDA) in a ci